Alantra advised Weener Plastics backed by 3i Group on the acquisition of Grupo Proenfar

Apr 2018

Buy-side advisory

Alantra advised Weener Plastics, a leading supplier of innovative plastic packaging solutions, on the acquisition of Grupo Proenfar, a Colombian-based manufacturer of plastic packaging solutions for the pharmaceutical, health, cosmetic, and complementary sectors.

The transaction was a great cross-border effort with professionals from the Bógota, Buenos Aires and Amsterdam offices. With this acquisition Weener Plastics will strengthen its geographic footprint in Latin America, add new innovative products to its existing portfolio and increase its market share in strategic product categories as well as enter new markets. Proenfar and Weener Plastics complement each other perfectly and the combined company will realize revenues of approximately EUR 400m.

Roel Zeevat, Chief Executive Officer of Weener Plastics, comments: “I am delighted by the acquisition of Proenfar which expands our offering into new geographies and products. The company is a leading player in the Latin American plastic dispensing packaging market and is very focused on innovation, with 40 R&D employees dedicated to launching new products and improvements, which will benefit our customers. We look forward to working with our new colleagues at Proenfar to drive further growth in our business.”

Weener Plastics, founded in 1960, is a full service global supplier of innovative plastic packaging solutions. The company is headquartered in Ede, The Netherlands and designs, develops and manufactures added value Caps & Closures, Roll-on Balls, Jars and Bottles for the Personal Care, Food & Beverage and Home Care markets. The company employs more than 3,000 people and has 25 facilities in 16 countries worldwide.

Headquartered in Bogotá, Colombia, Proenfar employs more than 1,600 people and has four production plants in Colombia, Argentina and Mexico. Founded in 1946, the company has long-standing customer relationships with multinational and local companies in the pharmaceutical and personal care markets. The exports of the group contribute to approximately 30 per cent of its revenues and the products are distributed to more than 20 countries.